Blood:通过去乙酰化激活LMO2对造血作用和T-ALL病的发生都必不可少

2019-08-01 MedSci MedSci原创

LMO2(造血转录因子LIM结构域-only-2)是TAL1转录复合体的成员之一,在早期造血中发挥重要作用,常在T细胞急性淋巴细胞白血病(T-ALL)患者中激活。近期,研究人员发现LMO2是通过烟酰胺磷脂酰转移酶(NAMPT)/去乙酰化酶2 (SIRT2)通路将第74位和78位上的赖氨酸脱乙酰化来激活的。LMO2去乙酰化使LMO2与LDB1相互作用,进而激活TAL1复合物。通过去乙酰化,NAMPT

LMO2(造血转录因子LIM结构域-only-2)是TAL1转录复合体的成员之一,在早期造血中发挥重要作用,常在T细胞急性淋巴细胞白血病(T-ALL)患者中激活。近期,研究人员发现LMO2是通过烟酰胺磷脂酰转移酶(NAMPT)/去乙酰化酶2 (SIRT2)通路将第74位和78位上的赖氨酸脱乙酰化来激活的。

LMO2去乙酰化使LMO2与LDB1相互作用,进而激活TAL1复合物。通过去乙酰化,NAMPT/SIRT2介导的LMO2活化对诱导多能干细胞(iPS)的造血分化和斑马鱼胚胎血液形成至关重要。

在T-ALL患者中,去乙酰化的LMO2可诱导TAL1复杂靶基因HHEX、NKX3.1表达,并可诱导LMO2自我调控。与此相一致,抑制NAMPT或SIRT2可通过消除LMO2的去乙酰化作用,抑制T-ALL细胞在体外生长、抑制其在体内种植。

综上所述,本研究所提出的新的分子机制或可作为T-ALL患者提供新的治疗可能,也可促进体外再生血液的技术发展。

原始出处:

Tatsuya Morishima, et al.LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.Blood 2019 :blood.2019000095; doi: https://doi.org/10.1182/blood.2019000095

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1329264, encodeId=f5811329264c3, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441318, encodeId=89da144131891, content=<a href='/topic/show?id=67311e013a7' target=_blank style='color:#2F92EE;'>#T-ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17013, encryptionId=67311e013a7, topicName=T-ALL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b94820128, createdName=紫砂壶, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494684, encodeId=7a481494684d4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370633, encodeId=a08f3e063319, content=学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Fri Aug 02 05:46:28 CST 2019, time=2019-08-02, status=1, ipAttribution=)]
    2019-08-03 膀胱癌
  2. [GetPortalCommentsPageByObjectIdResponse(id=1329264, encodeId=f5811329264c3, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441318, encodeId=89da144131891, content=<a href='/topic/show?id=67311e013a7' target=_blank style='color:#2F92EE;'>#T-ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17013, encryptionId=67311e013a7, topicName=T-ALL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b94820128, createdName=紫砂壶, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494684, encodeId=7a481494684d4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370633, encodeId=a08f3e063319, content=学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Fri Aug 02 05:46:28 CST 2019, time=2019-08-02, status=1, ipAttribution=)]
    2019-08-03 紫砂壶
  3. [GetPortalCommentsPageByObjectIdResponse(id=1329264, encodeId=f5811329264c3, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441318, encodeId=89da144131891, content=<a href='/topic/show?id=67311e013a7' target=_blank style='color:#2F92EE;'>#T-ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17013, encryptionId=67311e013a7, topicName=T-ALL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b94820128, createdName=紫砂壶, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494684, encodeId=7a481494684d4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370633, encodeId=a08f3e063319, content=学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Fri Aug 02 05:46:28 CST 2019, time=2019-08-02, status=1, ipAttribution=)]
    2019-08-03 俅侠
  4. [GetPortalCommentsPageByObjectIdResponse(id=1329264, encodeId=f5811329264c3, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441318, encodeId=89da144131891, content=<a href='/topic/show?id=67311e013a7' target=_blank style='color:#2F92EE;'>#T-ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17013, encryptionId=67311e013a7, topicName=T-ALL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6b94820128, createdName=紫砂壶, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494684, encodeId=7a481494684d4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94995, encryptionId=084d9499599, topicName=造血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caed9138962, createdName=俅侠, createdTime=Sat Aug 03 14:28:00 CST 2019, time=2019-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370633, encodeId=a08f3e063319, content=学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Fri Aug 02 05:46:28 CST 2019, time=2019-08-02, status=1, ipAttribution=)]
    2019-08-02 深海的鱼

    学习学习学习学习

    0